Skip to main content
Navigate Up
Sign In

Welcome to the Department of Neurology

Neurology Banner Image
 

Movement Disorders

Clinical Research



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: (view all)

Title (Please click on the title to see approved advertisement) Principal Investigator PRA
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia: A Pilot Project Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Functional Connectivity of the Motor Network in Two Major Subtypes of Parkinson Disease Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Natural History and Biospecimen Repository for Dystonia Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Neural Mechanisms of Reflexive Blinking and Eye Muscle Spasms in Blepharospasm Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Please contact PRA for eligibility and information
Cortical physiology as a therapeutic target in Parkinson's disease related dementia and cognitive dysfunction Kluger, Benzi M., MD, MS Isabelle Buard, PhD
303-724-5973
Please contact PRA for eligibility and information
Cognitive Dysfunction in Parkinson's Disease Kluger, Benzi M., MD, MS Isabelle Buard, PhD
303-724-5973
Please contact PRA for eligibility and information
Using Multiplex Families to Map Genes that Modify Susceptibility and Age at Onset in Parkinson's Disease (also known as "The PaGeR Study") Parkinson’s Genetic Research Study- NIH Klepitskaya, Olga S., MD Kalie Petefish
303-724-8305
Eligibility and Information
A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC (part A) Followed by an Open-Label, Multiple-Treatment Study with MYOBLOC (part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects Klepitskaya, Olga S., MD Kalie Petefish
303-724-8305
Eligibility and Information
A Phase 3b, Prospective, Multicenter, Open-Label Extension Study to Assess Long Term Safety and Effectiveness of DYSPORT Using 2mL Dilution in Adults with Cervical Dystonia Klepitskaya, Olga S., MD Kalie Petefish
303-724-8305
Please contact PRA for eligibility and information
Efficacy and Safety Study of ADS-5102 (amantadine HCl) Extended Release (ER) Capsules for the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease Patients Leehey, Maureen A., MD Kalie Petefish
303-724-8305
Eligibility and Information
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers Leehey, Maureen A., MD Shannon Hall
303-724-2194
Please contact PRA for eligibility and information
Exploratory Study of Different Doses of Endurance Exercise in People With Parkinson Disease Margaret Schenkman, PT, PhD, FAPTA Toby Wellington
720-848-6376
Eligibility and Information